Cannabis capsules tested for joint pain relief in new study

NCT ID NCT06878417

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether daily cannabis extracts (CBD or THC) can reduce pain interference in people with hip or knee osteoarthritis. One hundred adults aged 40-80 will take either CBD, THC, or a placebo capsule daily for 8 weeks and track their symptoms remotely. The goal is to see if a larger trial is possible, not to prove the treatment works yet.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS OF KNEE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

osteoarthritis susceptibility 5 osteoarthritis susceptibility 6 osteoarthritis, hip osteoarthritis, knee

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • McGill University Health Centre/Montreal General Hospital

    RECRUITING

    Montreal, Quebec, H3G 1A4, Canada

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University Health Network

    RECRUITING

    Toronto, Ontario, M5G 2C4, Canada

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Women's College Hospital

    RECRUITING

    Toronto, Ontario, M5S 1B2, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact